Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution 2019-07-29 21:42
NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation 2019-07-28 21:47
Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development 2019-07-25 19:00
Mirae Asset Launches China Biotech and Cloud Computing themed ETFs in Hong Kong 2019-07-25 09:00
Global Cord Blood Corporation Files Its Annual Report on Form 20-F 2019-07-24 04:16
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections 2019-07-23 12:48
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center 2019-07-22 09:08
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US 2019-07-22 07:00
Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument 2019-07-17 08:15
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline 2019-07-10 15:09
Accutest Biologics Private Limited (ABPL) Receives the Prestigious OECD-Good Laboratory Practice (GLP) Certification, a First-of-its-kind in India 2019-07-09 14:30
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia 2019-07-06 06:00
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study 2019-07-04 21:05
Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2019 2019-07-03 18:13
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer 2019-07-03 04:28
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan) 2019-06-27 12:21
Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors 2019-06-27 09:00
Purecircle Holdings Announces Name Change to Pure CE 2019-06-26 17:21
FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy 2019-06-24 17:00
Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial 2019-06-24 09:00
1 180 181 182 183 184 228